Spinal Muscular Atrophy Legislation Update

Reading time: 1 – 2 minutes

Back in July, I wrote that spinal muscular atrophy (SMA) legislation was going to soon be introduced in Congress.

Prior to the August recess, legislation to enhance federal support for Spinal Muscular Atrophy (SMA) research was introduced in the U.S. House of Representatives by Congressmen Patrick Kennedy (D-RI) and Eric Cantor (R-VA). The bill, H.R. 3334, would authorize the Secretary of Health and Human Services to conduct activities to rapidly advance treatments for spinal muscular atrophy, neuromuscular disease and other pediatric diseases. More information can be found on GovTrack.us.

The FightSMA website reports that U.S. Senators Debbie Stabenow (D-MI) and Johnny Isakson (R-GA) will introduce companion legislation in the Senate when Congress returns from its August district work period.

You can read more about spinal muscular atrophy and “The SMA Treatment Acceleration Act” here.

About the Author

Walter Jessen, Ph.D. is a Data Scientist, Digital Biologist, and Knowledge Engineer. His primary focus is to build and support expert systems, including AI (artificial intelligence) and user-generated platforms, and to identify and develop methods to capture, organize, integrate, and make accessible company knowledge. His research interests include disease biology modeling and biomarker identification. He is also a Principal at Highlight Health Media, which publishes Highlight HEALTH, and lead writer at Highlight HEALTH.